Hematopoietic Stem Cells Transplantation Industry - Regional Synopsis
North American Market Forecast
Hematopoietic stem cells transplantation market in North America is predicted to account for the largest share of 40% by 2037 impelled by the presence of major key players in the region. This has led to increasing mergers and acquisitions in the region which has led to the development of advanced hematopoietic stem cell transplantation treatment. For instance, in 2021, Avalon GloboCare Corp. acquired Hebei Senlang Biotechnology Co. Ltd. to create a strong pipeline that comprises over 14 universal, autologous, "off-the-shelf" CAR-T and CAR-γδT cell therapy candidates to enhance cutting-edge cell/gene engineering and exclusive cell expansion knowledge with exceptional therapeutic efficacy and safety profile.
APAC Market Statistics
The APAC hematopoietic stem cells transplantation market is estimated to be the second largest, during the forecast timeframe led by growing medical tourism. India is becoming a major destination for medical tourism, providing people from all over the world with high-quality healthcare at reasonable prices, and cutting-edge medical facilities. India has become a popular location for people undergoing stem cell transplants aided by the availability of cutting-edge facilities, skilled medical personnel, and cutting-edge technology that attracts medical tourists who may not be able to pay or obtain them in their native countries.
